CLOV analyst estimates
Clover Health (CLOV) analyst ratings, the average price target and its range, and every firm's latest call.
CLOV analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 28, 2026 | Needham | Clover Health initiated with a Buy at Needham | $6.00 |
| Sep 10, 2026 | Deutsche Bank | Clover Health initiated with a Buy at Deutsche Bank | $6.00 |
| Aug 6, 2026 | UBS | Clover Health price target raised to $5 from $4.75 at UBS | $5.00 |
| Jul 21, 2026 | Canaccord Genuity | Clover Health price target raised to $5.50 from $4.20 at Canaccord | $5.50 |
| Jun 11, 2026 | UBS | Clover Health price target raised to $4.75 from $2.75 at UBS | $4.75 |
| Jun 4, 2026 | Canaccord Genuity | Clover Health price target raised to $4.20 from $3.20 at Canaccord | $4.20 |
| Oct 21, 2025 | Leerink Partners | Clover Health (CLOV) PT Raised to $3 at Leerink Partners | $3.00 |
| Dec 17, 2024 | Craig-Hallum | Clover Health initiated with a Buy at Craig-Hallum | $6.00 |
| Aug 6, 2024 | Canaccord Genuity | Clover Health (CLOV) PT Raised to $2.50 at Canaccord Genuity | $2.50 |
| Nov 16, 2022 | Citigroup | Citigroup Maintains Neutral on Clover Health Investments, Lowers Price Target to $1.8 | $1.80 |
- 4 firms rate CLOV: 2 buy, 2 hold, 0 sell.
- The average price target is $5.62 from 4 analysts, from $5.00 to $6.00.
Updated 2026-11-03 00:00 UTC